# Advanced Lung Cancer Treatment With Metformin and Chemo-Radiotherapy

> **NCT02115464** · PHASE2 · TERMINATED · sponsor: **Ontario Clinical Oncology Group (OCOG)** · enrollment: 54 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Metformin plus Chemo-radiotherapy
- **RADIATION:** Chemo-radiotherapy

## Key facts

- **NCT ID:** NCT02115464
- **Lead sponsor:** Ontario Clinical Oncology Group (OCOG)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12-17
- **Primary completion:** 2020-03-09
- **Final completion:** 2020-04-21
- **Target enrollment:** 54 (ACTUAL)
- **Why stopped:** The accrual rate was not high enough to reach the target sample size.
- **Last updated:** 2020-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02115464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02115464, "Advanced Lung Cancer Treatment With Metformin and Chemo-Radiotherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02115464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*